PharmGKB:  The Pharmacogenetics and Pharmacogenomics Knowledge Base
Search PharmGKB:?
 

Annotated PGx Gene Information for ADRB1

Submitted by: Michael A. Pacanowski and Julie A. Johnson (PEAR)
Reviewed by: Scott T. Weiss (PHAT)
Submitted date: February 25, 2006
Revised: February 12, 2007

Jump To:

Gene HGNC Name: ADRB1
Gene Common Name: Beta1 Adrenergic Receptor (Beta-1-AR)
Introductory Information: The Beta1-adrenergic receptor (Beta-1-AR) is a G-protein-coupled receptor that was first characterized by its pharmacological specificity. The gene for this receptor (ADRB1) was cloned in 1987 from a placental cDNA library and subsequently mapped to chromosome 10q24-q26 (10q25.3) [PMID: 2825170, 2154750]. The intronless gene consists of 1,714 bp and codes for a 51.3 kDa protein consisting of 477 amino acid residues. Beta-1-ARs are the predominant Beta-AR subtype expressed in cardiac tissue, where they mediate the heart rate and contractility. Beta-1-AR expression in renal, vascular, and adipose tissues is also physiologically important.

The 145 A>G (Ser49Gly) and 1165 C>G (Arg389Gly) variants are the most common and well studied in the Beta-1-AR gene. The variant at codon 49 results in increased agonist-promoted desensitization, whereas the codon 389 polymorphism alters G-protein coupling and adenylyl cyclase activity. The impact of these polymorphisms on cardiovascular disease and drug response has been the subject of numerous investigations, which were recently reviewed in detail [PMID: 16120061]. Three other validated SNPs are currently documented in dbSNP, two of which have been confirmed in resequencing efforts (SeattleSNPs). Several other SNPs have been reported but not validated [PMID: 11102996, 10794544]. The functional consequences of these other polymorphisms are unknown.
Key PubMed IDs: 2825170, 2154750, 11102996, 10794544, 16120061
Key Pathways: Beta-agonist and Beta-blocker Pathway, Antiarrhythmic Drug Pathways, Sympathetic Nerve Pathway
Drugs/Substrates: Beta adrenergic antagonists  [PMID: 12844134, 16189366, 15735607, 15864115, 15861037, 11052857, 16153393, 11787477, 12709726, 14534524, 14502278, 12921807, 16402084], Metoprolol [PMID: 12844134, 15735607, 15864115, 14534524, 12921807, 16402084], Carvedilol  [PMID: 15861037], Bisoprolol  [PMID: 15861037, 16325050], Atenolol  [PMID:11787477, 12709726], Beta adrenergic agonists [PMID: 11753577, 16325050, 15564877], Isoproterenol, Dobutamine [PMID: 11753577, 16325050, 15564877], Epinephrine hydrochloride, Norepinephrine [PMID: 12383575, 12540530], Dopamine, Hydrochlorothiazide [PMID: 15864129, 14553962, 16109321], Xenobiotics  [PMID: 11942593], Antidepressants [PMID: 12815745], Acebutolol 
Phenotypes/Diseases: Acquired Long QT Syndrome (aLQTS) [PMID: 11942593], Angina Pectoris [PMID: 16189366, 11704005, 16210433, 12090746], Cardiovascular Diseases [PMID: 16402084, 11787477, 12709726, 12844134, 14534524, 15864129, 14553962, 16109321, 16153393, 15735607, 15864115, 15861037, 14502278, 12921807, 16189366, 11704005, 16210433, 12090746], Heart Failure [PMID: 16153393, 15735607, 15864115, 15861037, 14502278, 12921807], Heart Failure, Congestive [PMID: 16153393, 15735607, 15864115, 15861037, 14502278, 12921807], Hypertension [PMID: 16402084, 11787477, 12709726, 12844134, 14534524, 15864129, 14553962, 16109321], Ischemia [PMID: 11704005, 16189366, 16210433, 12090746], Myocardial Ischemia [PMID: 11704005, 16189366, 16210433, 12090746], Obesity [PMID: 15685248, 15917856, 15833937, 12032746, 15833937, 15479221], Sleep Apnea, Obstructive [PMID: 16122377], Coronary Arteriosclerosis [PMID: 16189366, 11704005, 16210433, 12090746], Angina, Unstable  [PMID: 16189366, 12090746], Myocardial Infarction [PMID: 16189366, 12090746], Essential hypertension [PMID: 16402084, 11787477, 12709726, 12844134, 14534524, 15864129, 14553962, 16109321], Depression [PMID: 12815745], Alzheimer Disease [PMID: 15212839]
Important Variants: ADRB1:49Ser>Gly, ADRB1:389Arg>Gly
The PGRN is financially supported by grants from NIGMS, NHLBI, NHGRI, NIEHS, NCI, and NLM within the NIH, HHS. PharmGKB is managed at Stanford University. This work is supported by the NIH/NIGMS Pharmacogenetics Research Network and Database (U01GM61374). ©2001-2008 PharmGKB.